Safety and Feasibility of Immuno-OCT
Conditions: Colon Carcinoma; Barrett Esophagus; Gastrointestinal Dysplasia Intervention: Drug: Bevacizumab-800CW Sponsor: University Medical Center Groningen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab
Conditions: Colorectal Cancer; Peritoneal Metastases Interventions: Drug: Irinotecan; Drug: FOLFOX regimen; Drug: Bevacizumab Sponsor: Catharina Ziekenhuis Eindhoven Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
Condition: Colorectal Cancer Interventions: Drug: all trans Retinoic Acid; Drug: Atezolizumab; Drug: Bevacizumab Sponsors: University of Texas Southwestern Medical Center; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer
Condition: Colorectal Cancer Interventions: Drug: all trans Retinoic Acid; Drug: Atezolizumab; Drug: Bevacizumab Sponsors: University of Texas Southwestern Medical Center; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
Condition: Cervical Cancer Interventions: Drug: TQB2868 injection; Drug: Paclitaxel injection; Drug: Cisplatin injection; Drug: Carboplatin injection; Drug: Bevacizumab injection Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials